Form 4: BioCorRx Inc. Director Lourdes Felix Acquires Shares as Part of Compensation Agreement
SEC Form 4 Filing
Lourdes Felix, CEO, CFO, and Director of BioCorRx Inc., acquired 10,204 shares of common stock on June 28, 2024, as part of her director compensation agreement.
Summary
- Lourdes Felix, CEO, CFO, and Director of BioCorRx Inc. [BICX], reported a transaction on June 28, 2024, where she acquired 10,204 shares of common stock.
- The acquisition was made under a Director Agreement dated March 1, 2019, where Ms. Felix receives shares equivalent to $5,000 per fiscal quarter for her services as a board member.
- The share issuance is based on the average closing price of the company's common stock on the three trading days immediately preceding the last day of the fiscal quarter, which was $0.49.
- Following the transaction, Ms. Felix directly owns 90,599 shares of BioCorRx Inc.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The transaction is part of a pre-existing agreement and reflects ongoing compensation for a key executive. It doesn't indicate any significant positive or negative shift in the company's prospects.
Positives
- The acquisition of shares by a key executive and director demonstrates her continued alignment with the company's interests.
- The Director Agreement provides a structured compensation plan, ensuring consistent compensation for board service.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Related Party Transactions
- The issuance of shares to Lourdes Felix under the Director Agreement constitutes a related party transaction, as she is both an executive and a director of the company.
Stakeholder Impact
- The share issuance dilutes existing shareholders' equity to a minor extent.
- The compensation structure ensures continued engagement of a key executive and director.
Key Dates
| Date | Description |
|---|---|
| March 1, 2019 | Date of the Director Agreement between BioCorRx Inc. and Lourdes Felix. |
| June 28, 2024 | Date of the transaction where Lourdes Felix acquired 10,204 shares of common stock. |
| July 8, 2024 | Date of signature for the Form 4 filing. |
Keywords
BioCorRx Inc., Lourdes Felix, Director, CEO, CFO, Share Acquisition, Form 4, Director Agreement, Compensation, BICX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.